Compare MFIC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MFIC | IART |
|---|---|---|
| Founded | 2004 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2004 | 1995 |
| Metric | MFIC | IART |
|---|---|---|
| Price | $11.77 | $13.56 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 7 |
| Target Price | $12.96 | ★ $15.00 |
| AVG Volume (30 Days) | 615.1K | ★ 849.4K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | ★ 12.75% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.07 | N/A |
| Revenue | $324,678,000.00 | ★ $1,642,966,000.00 |
| Revenue This Year | $9.27 | $3.26 |
| Revenue Next Year | N/A | $2.71 |
| P/E Ratio | $11.16 | ★ N/A |
| Revenue Growth | ★ 11.35 | 4.99 |
| 52 Week Low | $10.18 | $10.87 |
| 52 Week High | $14.74 | $27.13 |
| Indicator | MFIC | IART |
|---|---|---|
| Relative Strength Index (RSI) | 42.24 | 55.03 |
| Support Level | $11.80 | $13.27 |
| Resistance Level | $12.02 | $14.35 |
| Average True Range (ATR) | 0.16 | 0.58 |
| MACD | -0.03 | 0.13 |
| Stochastic Oscillator | 8.80 | 56.57 |
MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.